{"id":"W2893765519","doi":"10.1038/s41375-018-0265-z","title":"Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Vanderbilt University; York University; Eberhard Karls Universität Tübingen; McMaster University; NYU Langone Medical Center; Kaiser Permanente","keywords":"Medicine; Refractory (planetary science); Minimal residual disease; Salvage therapy; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Lymphoblastic Leukemia; Leukemia; Chemotherapy; Pediatrics; Oncology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002905157,0.0002261604,0.000549722,0.0002409392,0.0002447319,0.000298179,0.000179396,0.0002506911,0.0003535522],"category_scores_gemma":[0.0009242711,0.0001186995,0.0002022461,0.0004410215,0.0002841723,0.0002458833,0.0002651959,0.000482858,0.0001149621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000362352,"about_ca_system_score_gemma":0.0004618325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00111286,"about_ca_topic_score_gemma":0.002344059,"domain_scores_codex":[0.9997595,0.0001008997,0.0000262811,0.00002864347,0.00003808696,0.00004643809],"domain_scores_gemma":[0.9996792,0.00008318511,0.0001337646,0.00001677971,0.00001520802,0.0000719354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.005598222,0.0003778193,0.8354377,0.0003448226,0.0001737714,0.01745065,0.0008835385,0.0008877548,0.01791789,0.000245874,0.001678572,0.1190033],"study_design_scores_gemma":[0.0007400269,0.01257325,0.9110686,0.0001296661,0.0004813203,0.05298845,0.0009843424,0.001546087,0.008402667,0.000216689,0.01084203,0.00002690777],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950004,0.003936091,0.0001813213,0.0001508668,0.000007879627,0.00002833188,0.00006721276,0.00001392369,0.0006141145],"genre_scores_gemma":[0.9965276,0.00261414,0.0003997649,0.0001540014,0.00003312068,0.00002486398,0.0001583479,0.000004919138,0.00008333479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00111286,"threshold_uncertainty_score":0.002629042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008638915841045569,"score_gpt":0.2502595223216064,"score_spread":0.2416206064805608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}